IDRI to present at India - U.S. Forum
Dr. Christopher Fox to discuss IDRI's technology transfer efforts
SEATTLE, Nov. 29, 2011 /PRNewswire-USNewswire/ -- The Infectious Disease Research Institute (IDRI) announced today that IDRI formulation scientist Dr. Christopher Fox will present at this week's Forum on The U.S.-India Commercial Relationship: The Knowledge Economy. The forum, to be held in Washington DC, is sponsored by the University of Washington Jackson School of International Studies, and will also include noted speakers from the U.S. Departments of State and Commerce, the India Ministry of Commerce, and other high level officials.
The forum has been organized for members of Congress, their staff, members of the U.S. India Business Council, policy makers, members of think tanks and academia. A series of four panels will explore developments in the U.S.-India economic relationship. Dr. Fox will discuss IDRI's efforts to transfer technology to India collaborators related to IDRI's vaccine technology.
The U.S. - India Commercial Relationship: The Knowledge Economy
Jackson School Information
South Asia Center
Thursday December 1, 2011
9:00 a.m. to 5:15 p.m.
1300 Pennsylvania Avenue NW, Washington, DC
About IDRI – Translating science into global health solutions
IDRI is a Seattle-based not-for-profit organization committed to applying innovative science to the research and development of products to prevent, detect, and treat infectious diseases of poverty. By integrating capabilities — including early stage drug discovery, preclinical testing, manufacturing, and clinical trials — IDRI strives to create an efficient pathway bringing scientific innovation from the laboratory to the people who need it most. www.idri.org
SOURCE Infectious Disease Research Institute (IDRI)
More by this Source
IDRI and Medicago Report Positive Results for Phase I Clinical Trial for an H5N1 Vaccine
Apr 17, 2013, 14:51 ET
IDRI and Medicago to present data at the World Vaccine Congress
Apr 09, 2013, 07:00 ET
IDRI And OrangeLife Register Rapid Diagnostic For Leprosy For Use In Brazil
Jan 24, 2013, 08:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.